Compare dividend stocks

JNJ vs PFE

Pfizer, Inc. (PFE) provides a 6.87% dividend yield, notably higher than Johnson & Johnson's (JNJ) 2.12%. JNJ, however, boasts stronger dividend growth with a 29-year streak and a "safe" dividend rating, supported by a lower payout. In contrast, PFE presents a more favorable valuation with a lower P/E and a "fair" margin of safety, differing from JNJ's "expensive" status.

JNJ JN
JNJ
PFE PF
PFE

Key differences

Yield

JNJ

PFE 6.09%

CAGR 5y

JNJ JN
JNJ

+5.2%

PFE +3.6%

Safety

JNJ JN
JNJ

Safe

PFE At risk

Dividend score

PFE PF
PFE

5/10

JNJ 2/10

JNJ JN
JNJ Yield Growth Momentum Safety Value Health
2 · Weak Safe
PFE PF
PFE Yield Growth Momentum Safety Value Health
5 · Fair At risk

Price

273.4 USD 28.2 USD

Today

+0.8% +3.6%

Dividend/share

1.7 USD

6.09%

Growth (TTM)

+4.4% +1.2%

CAGR 3y

+4.8% +2.4%

+5.2% +3.6%

29y 16y

Dividend status

Aristocrat (25y+) Contender (10y+)

13.9y 20.1y

Dividend score

2/10 5/10

Safety

Safe At risk

Quantic · Free

Unlock the full valuation comparison

Chowder number, fair value and Dividend Yield Theory for every stock — plus track them in your portfolio.

€0

Need more? Pro adds portfolios, options income tracking & more AI. See Pro →